Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial
Public Deposited- Creator
- Brew, Bruce J
- Halman, Mark
- Catalan, Jose
- Sacktor, Ned
- Price, Richard W
- Brown, Steve
- Atkinson, Hamp
- Clifford, David B
- Simpson, David
- Torres, Gabriel
- Hall, Colin
- Power, Christopher
- Marder, Karen
- Arthur, Justin C. Mc
- Symonds, William
- Romero, Carmen
- Abstract
- To determine the efficacy of adding abacavir (Ziagen, ABC) to optimal stable background antiretroviral therapy (SBG) to AIDS dementia complex (ADC) patients and address trial design.
- Date of publication
- 2007
- Keyword
- DOI
- Identifier
- Publisher DOI: https://doi.org/10.1371/journal.pctr.0020013
- PMID: 17401456
- PMCID: PMC1845158
- Onescience id: bae231686ea1a0f70d9d1f078ff7b8a47298ca02
- Resource type
- Article
- Rights statement
- In Copyright
- Journal title
- PLoS Clinical Trials
- Journal volume
- 2
- Journal issue
- 3
- Page start
- e13
- Language
- English
- ISSN
- 1555-5887
Relations
- Parents:
- In Collection:
This work has no parents.
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
EuropePMC-PMC1845158.pdf | 2020-10-31 | Public | Download |